Google Health Manager Discusses User Feedback


Loading...

By Neil Versel, contributing editor

November 4, 2008 | Google Health product manager Roni Zeiger remains highly optimistic about the fledgling but high-profile personal health record (PHR) service and data-aggregation platform, but is trying to assuage concerns about consumer privacy and tamp down expectations that the Internet search leader might be able to cure all that ails health care.

“A PHR and platform is necessary but not sufficient,” Zeiger says, echoing the words of national health-IT coordinator Robert Kolodner. (See “Kolodner et al Remain Optimistic for Health 2.0.”) Zeiger spoke to Digital HealthCare & Productivity shortly after appearing on stage with Kolodner and others at a health 2.0 conference in San Francisco. According to Zeiger, there have to be regular and secure data feeds from multiple sources, including physician and hospital electronic health records (EHRs), insurance companies, laboratories, and pharmacies.

Zeiger says that feedback from test users, largely based on a three-month trial with the Cleveland Clinic that ended in August, has been “surprising that it’s consistently supportive.” However, the chief complaint, according to Zeiger, is that users say, “I want to be able to get my data.” He also says consumers have consistently given him a single message: “We want more.”

Anecdotally, patients have regularly been asking doctors for electronic access to personal health information, something that runs counter to the deeply ingrained culture in medicine.

There also remains skepticism about a company like Google having access to such sensitive information. Zeiger says Google Health doesn’t have any plans to put ads on its pages, reiterating the promise made by Google chief executive Eric Schmidt at the 2008 Healthcare Information and Management Systems Society (HIMSS) conference. (See “Google CEO Discusses Google Health.”)

Zeiger says Google Health is being built on two fundamentals: transparency and choice. “We promise that we won’t sell their data, ever,” he says. This runs counter to Google’s corporate strategy of monetizing Internet search results, but Schmidt said Feb. 28 that he expects Google Health to drive users to other, revenue-producing Google services, including the main search engine.

“We won’t share their data unless they tell us it’s OK,” Zeiger adds. He notes that the company has published privacy and security guidelines that Google Health partners must follow. The focus is squarely on consumer control of data, based on opt-in consent.

Google Health also touts a recent partnership with PDX Inc. (Fort Worth, Texas), a company that aggregates data for about 65 pharmacy chains so they can share prescription information in real time. PDX provides patients with medication records through its pharmacy customers and its rx.com Web portal. The company is making prescription data available for import into Google Health, starting with customers of the New York City-based Duane Reade pharmacy chain.

“Fifty million-plus people will be able to access their medication histories in ways that weren’t possible before,” Zeiger says. That is a while off, however. Right now, Google Health’s role is “helping to build the pipes” for interoperable data exchange.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

oracle_clinical
eClinical Visions - Clinical Trial Management: Enabling Operational Efficiency
Sponsored by Oracle

Read how contributors from Genzyme, Duke Clinical Research Institute, Accenture, Oracle Health Sciences and others address some of the most pertinent challenges facing the biopharmaceutical industry including... Globalization of clinical trials driven by the need to reduce costs and recruit participants; greater outsourcing; escalating regulatory demands; increased trial complexity; and post-marketing studies. Download this paper to gain new insight into:

  • Recent progress made in addressing these challenges
  • Expert opinion on clinical trial management systems (CTMS) for improving trial efficiencies
  • How to cut trial costs and enhance the productivity of trial participants


oracle_RDC
Remote Data Capture – Acquisition and Analysis
Sponsored by Oracle

Today nearly half of all clinical trials are conducted electronically, and rising! Electronic Data Capture (EDC) technology provides industry-wide opportunities, along with challenges, that are being addressed. In this informative report industry experts and users from Pfizer, PPD, C3i and Oracle Health Sciences discuss the impact of EDC and its newest zero footprint; online iteration.  It can used anywhere, world-wide, where the Internet is available while placing greater onus on global trial support. The critical focus of this new technology is that it must support the work of the person at the heart of the clinical trial system– the investigator. Download this report to learn more about:

  • Trends and Issues in an Electronic Clinical Data Management World
  • The New Remote Data Capture Paradigm 
  • Improving and Monitoring Clinical Data Management in the eClinical Age
  • Optimizing and Supporting Remote Data Capture


oracle_video
Technology Video Report: A Day in the Life with Remote Data Capture (Next-Gen EDC)
Sponsored by Oracle
See why Oracle Remote Data Capture (RDC) Onsite is the next generation in electronic data capture with its user-friendly method to collect, clean, review, and verify clinical trial data. Providing unprecedented performance with real-time data capture, Oracle RDC Onsite simplifies source data verification. With a clear, consistent view of study data across all sites, the benefits include reduced monitoring time, decreased queries and discrepancies, and less time to database lock.



Life Science Webcasts & Podcasts

Predict or Perish! Shaping the Practices of Clinical Trials
Decisionview webinarSponsored by:  DecisionView

Predictive Analytics are a key differentiator in running your clinical trials successfully through 2010 and beyond. They will help you to optimize your patient enrollment, reduce your clinical operations costs and minimize your financial liability in the clinical supply chain. In this session, you will:
• Learn what predictive analytics are and what they are not
• Understand why you need predictive analytics to run your clinical trials, and
• Explore how predictive analytics will shape the future of clinical trials

Download Now. 

 



More Podcasts

Job Openings

The University of Washington Department of Genome Sciences is seeking a LINUX SYSTEMS ENGINEERING MANAGER to lead a team in a diverse scientific computing environment that includes multiple HPC systems, petascale storage, and custom application servers. Apply online at UW Hires for req number 61505.  http://www.washington.edu/admin/hr/jobs/

Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.